A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Belgium

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational

Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Rocatinlimab
Sponsor:Amgen Inc.

Contact Research Centre

Respiratory syncytial virus infection

Not recruiting

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo

Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
Sponsor:GlaxoSmithKline Biologicals

Contact Research Centre

Familial hypertriglyceridaemia+1

Not recruiting

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

Study of ISIS 678354 for Patients with Severe High Triglycerides

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:ISIS 678354 sodium salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Anderlecht

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials investigating new treatments for various cancers, including bladder cancer, acute myeloid leukemia, and advanced breast cancer. Studies focus on innovative combination therapies and targeted treatments.

Non-muscle invasive bladder cancer therapy
Metastatic breast cancer treatments
Gastroesophageal cancer interventions

02 Immunology and Inflammatory Conditions

Clinical investigations targeting chronic inflammatory conditions and autoimmune disorders, including Crohn's Disease, Ulcerative Colitis, and Psoriatic Arthritis.

Inflammatory bowel disease therapies
Novel arthritis treatments
Sjögren's Disease interventions

03 Infectious Diseases

Studies examining innovative approaches to combat various infections, including urinary tract infections and viral diseases. Research includes vaccine development and antimicrobial therapies.

UTI vaccine development
RSV vaccination studies
Hepatitis D treatments

04 Cardiovascular and Pulmonary Studies

Research focusing on pulmonary hypertension and cardiovascular disease management, with emphasis on innovative therapeutic approaches and disease prevention.

Pulmonary arterial hypertension treatments
Cardiovascular disease interventions
Post-cardiac arrest care

Back to Belgium All countries